SC 13G/A:超过5%持股股东披露文件(修正)-Danaher Corporation(0.0%),Danaher Ventures LLC(0.0%)
SC 13D/A:超过5%持股股东披露文件(修正)-Michael P. Rubin(45.9%),Northpond Ventures, LP(44.7%)等
SC 13D/A:超过5%持股股东披露文件(修正)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%)等
4:持股变动声明-董事 Krueger Todd
4:持股变动声明-董事 Hodges Michael R.
4:持股变动声明-董事 Hlavinka Sarah E.
4:持股变动声明-董事 Golub Steven J
4:持股变动声明-董事 Weissman James B
3:首次持股声明-董事 Krueger Todd
3:首次持股声明-董事 Golub Steven J
3:首次持股声明-董事 Hlavinka Sarah E.
3:首次持股声明-董事 Weissman James B
3:首次持股声明-董事 Hodges Michael R.
SC 13D/A:超过5%持股股东披露文件(修正)-Michael P. Rubin(47.7%),Northpond Ventures, LP(46.5%)等
SC 13D/A:超过5%持股股东披露文件(修正)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%)等
SC 13D/A:超过5%持股股东披露文件(修正)-Michael P. Rubin(47.6%),Northpond Ventures, LP(46.4%)等
SC 13D/A:超过5%持股股东披露文件(修正)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%)等
4:持股变动声明-董事 Witney Frank
4:持股变动声明-董事 TUMOLO ANNETTE
4:持股变动声明-董事 TSINGOS CHRISTINE A
暂无数据
暂无数据